False-positive gonorrhea test results with a nucleic acid amplification test: the impact of low prevalence on positive predictive value.

Five false-positive gonorrhea test results from a private laboratory using a nucleic acid amplification test led to an investigation by the Hawaii State Department of Health. No unexplained increase or variation in the laboratory's positive gonorrhea test results was detected. The proportion of positive gonorrhea test results among tests performed in the population was 1.06%. The calculated positive predictive value (PPV) of the test in this setting was 60%. Documentation of sexual histories was lacking for all cases. It is imperative to obtain a sexual history for both assessing sexually transmitted disease (STD) risk and interpreting STD test results. The possibility that positive test results may be false should be considered when patients have unanticipated positive test results. Clinicians who perform STD screening tests should know the approximate prevalence of STDs in the population being screened and have a conceptual understanding of PPV and the impact of low prevalence on screening tests with imperfect specificity.

[1]  S. M. Rogers,et al.  LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value , 2003, Sexually transmitted infections.

[2]  T. Quinn,et al.  Multicenter Evaluation of the AMPLICOR and Automated COBAS AMPLICOR CT/NG Tests for Detection ofChlamydia trachomatis , 2000, Journal of Clinical Microbiology.

[3]  C. Hamilton,et al.  The proactive sexual health history. , 2002, American family physician.

[4]  P. Pyett,et al.  Barriers to sexual history taking in general practice. , 1996, Australian family physician.

[5]  Robert E. Johnson,et al.  Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections -- 2002 , 2002 .

[6]  C. Berg,et al.  Abortion surveillance--United States, 1999. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[7]  J. Kelly,et al.  Enhancing the Specificity of the COBAS AMPLICOR CT/NG Test forNeisseria gonorrhoeae by Retesting Specimens with Equivocal Results , 2001, Journal of Clinical Microbiology.

[8]  J. Fortenberry,et al.  Practice patterns for the elicitation of sexual history, education, and counseling among providers of STD services: results from the gonorrhea community action project (GCAP). , 1999, Sexually transmitted diseases.

[9]  C. Risen.  A guide to taking a sexual history. , 1995, The Psychiatric clinics of North America.

[10]  S. M. Rogers,et al.  Untreated gonococcal and chlamydial infection in a probability sample of adults. , 2002, JAMA.

[11]  J. S. St. Lawrence,et al.  STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians. , 2002, American journal of public health.

[12]  J. Thornby,et al.  Why Doctors Have Difficulty With Sex Histories , 1990, Southern medical journal.

[13]  K. Schulz,et al.  Uses and abuses of screening tests , 2002, The Lancet.

[14]  G. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[15]  D. Livermore,et al.  Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002 , 2003, The Lancet.

[16]  M. Rivard,et al.  Do physicians assess lifestyle health risks during general medical examinations? A survey of general practitioners and obstetrician-gynecologists in Quebec. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.